Hormonal contraception and cervical cancer: does the correlation exist?
https://doi.org/10.30629/0023-2149-2023-101-4-5-194-197
Abstract
The article presents a systematic analysis of scientifi c publications concerning the eff ect of combined hormonal contraceptives on the risk of the development of cervical cancer. The following databases were used for literary search: PubMed, Cochrane, Google Scholar, elibrary.ru. Key words and their combinations were: “cervical cancer”, “cervical intraepithelial neoplasia”, “human papillomavirus”, “contraception”, “combined oral contraceptives”, “hormonal contraceptives”. 147 scientifi c publications have been analyzed, and 10 of them have been selected with the use of I/E criteria. Based on the analyzed literature, a conclusion was made. Long-term use of combined oral contraceptives against the background of persistence of the human papillomavirus increases the risk of developing cervical cancer.
About the Authors
I. S. Zakharov
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of Russia
Russian Federation
Russian Federation
Zakharov Igor S.
194044, Saint Petersburg
A. A. Schmidt
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of Russia
Russian Federation
Russian Federation
Schmidt Andrey A.
194044, Saint Petersburg
I. A. Pronsky
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of Russia
Russian Federation
Russian Federation
Pronsky Ilya A.
194044, Saint Petersburg
S. V. Beskrovny
Military Medical Academy named after S.M. Kirov of the Ministry of Defense of Russia
Russian Federation
Russian Federation
Beskrovny Sergey V.
194044, Saint Petersburg
V. G. Abashin
Central Military Clinical Hospital named after P.V. Mandryka of the Ministry of Defense of Russia
Russian Federation
Russian Federation
Abashin Viktor G.
107014, Moscow
References
1. The state of oncological care to the population of Russia in 2021. Ed. Kaprina A.D., Starinsky V.V., Shakhzadova A.O. Moscow, 2022:239. (In Russian)].
2. Malignant neoplasms in Russia in 2018 (morbidity and mortality). Ed. Kaprin A.D., Starinsky V.V., Petrova G.V. Moscow, 2019:250. (In Russian)].
3. Yelgina S.I., Zolotarevskaya O.S., Zakharov I.S. Cytological screening in the diagnosis of cervical cancer. Mother and child in Kuzbass. 2019;78(3):37–40. (In Russian)].
4. Smith J.S. Cervical cancer and use of hormonal conraceptives: a systematic review. Lancet. 2003;361:1159–1167.
5. Medical eligibility criteria for contraceptive use. 5th ed. Geneva: World Health Organization; 2015:192.
6. Fischer S., Kuebler U., Abbruzzese E., Breymann C., Mernone L., Ehlert U. Endogenous oestradiol and progesterone as predictors of oncogenic human papillomavirus (HPV) persistence. BMC Cancer. 2022;22(1):145. DOI: 10.1186/s12885-022-09247-3. PMID: 35123443; PMCID: PMC8818138.
7. Skorstengaard M., Lynge E., Napolitano G., Blaakær J., Bor P. Risk of precancerous cervical lesions in women using a hormone-197 containing intrauterine device and other contraceptives: a registerbased cohort study from Denmark. Hum. Reprod. 2021;36(7):1796– 1807. DOI: 10.1093/humrep/deab066. PMID: 33974685; PMCID: PMC8213448
8. Peng Y., Wang X., Feng H., Yan G. Is oral contraceptive use associated with an increased risk of cervical cancer? An evidencebased meta-analysis. J. Obstet. Gynaecol. Res. 2017;43(5):913–922. DOI: 10.1111/jog.13291
9. Xu H., Egger S., Velentzis L.S., O’Connell D.L., Banks E., Darlington-Brown J., Canfell K., Sitas F. Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30–44 years: A casecontrol study in New South Wales, Australia. Cancer Epidemiol. 2018;55:162–169. DOI: 10.1016/j.canep.2018.05.013
10. Asthana S., Busa V., Labani S. Oral contraceptives use and risk of cervical cancer-A systematic review & meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020;247:163–175. DOI: 10.1016/j.ejogrb.2020.02.014
11. Loopik D.L., IntHout J., Melchers W., Massuger L., Bekkers R., Siebers A.G. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study. Eur. J. Cancer. 2020;124:102–109. DOI: 10.1016/j.ejca.2019.10.009
12. Hull R., Mbele M., Makhafola T., Hicks C., Wang S.M., Reis R.M., Mehrotra R., Mkhize-Kwitshana Z., Kibiki G., Bates D.O., Dlamini Z. Cervical cancer in low and middle-income countries. Oncol. Lett. 2020;20(3):2058–2074. DOI: 10.3892/ol.2020.11754
13. Getinet M., Taye M., Ayinalem A., Gitie M. Precancerous Lesions of the Cervix and Associated Factors among Women of East Gojjam, Northwest Ethiopia, 2020. Cancer Manag. Res. 2021;13:9401–9410. DOI: 10.2147/CMAR.S338177
14. Adhikari I., Eriksson T., Luostarinen T., Lehtinen M., Apter D. The risk of cervical atypia in oral contraceptive users. Eur. J. Contracept. Reprod. Health Care. 2018;23(1):12–17. DOI:
15. 1080/13625187.2018.1431214
16. Pragout D., Laurence V., Baff et H., Raccah-Tebeka B., Rousset-Jablonski C. Contraception et cancer. RPC Contraception CNGOF [Contraception and cancer: CNGOF Contraception Guidelines]. Gynecol. Obstet. Fertil. Senol. 2018;46(12):834–844. DOI: 10.1016/j.gofs.2018.10.010
Review
For citations:
Zakharov I.S., Schmidt A.A., Pronsky I.A., Beskrovny S.V., Abashin V.G. Hormonal contraception and cervical cancer: does the correlation exist? Clinical Medicine (Russian Journal). 2023;101(4-5):194-197. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-4-5-194-197
Views:
612
Email this article 